Latest Reports

The “2024 China Ophthalmic Market Report” covers all aspects of China’s ophthalmic market, providing a comprehensive overview of the Chinese population and economic conditions, discussing key strategic issues, studying disease prevalence, and analyzing surgical and therapeutic approaches, including both commercialized and pipeline products. The report analyzes unit demand and revenue, and forecasts future performance over the next five years. Competitor share is analyzed by product category and 32 competitors are profiled, with discussion of their products, strategic market position, background, and outlook. 

Market Scope’s “2024 Ophthalmic Diagnostic Equipment Market Report” provides in-depth coverage of ophthalmic diagnostic equipment used during ophthalmic exams and procedures, analyzing over 800 devices from 115 manufacturers. This comprehensive report examines the factors shaping the market and identifies trends.  

The report analyzes markets for diagnostic technologies that include corneal topographers, various microscopes, anterior eye scanners, biometers, tonometers, fundus cameras, perimeters, refractors, slit lamps, and many more devices. For each device category, the report discusses pricing, competitor market share, the installed equipment base, and emerging technologies. 

The “2024 Cataract Surgical Equipment Market Report” provides in-depth analysis of the global cataract surgical equipment market, examining the market’s size and growth, as well as identifying important developments that may shape its future. Product coverage includes ultrasonic phaco machines, packs, and accessories; femtosecond laser-assisted cataract surgery systems; and photodisruptor lasers. 

The analysis focuses on the 2024 market and forecasts growth and evolution through 2029. Product demand is forecast in units and dollars, and market shares are analyzed by product category. Additionally, 21 competitors are profiled, with discussion of their products, strategic market position, background, and outlook. 

The “2024 Glaucoma Pharmaceuticals Market Report” analyzes the global and regional markets for glaucoma pharmaceuticals, identifying important trends and key factors for future success. The report provides forecasts through 2029 for branded prostaglandins, generic prostaglandins, beta blockers, carbonic anhydrase inhibitors, alpha agonists, fixed combo drugs, NO-donating compounds, and Rho-kinase inhibitors. The report also extensively discusses pipeline products, covering over 30 drug candidates that are currently under development. Additionally, 26 glaucoma pharmaceutical companies are profiled, with discussion of their products, strategic market position, background, and outlook.

Market Scope surveys United States cataract surgeons with an expanded list of questions during the first quarter of each year. Questions probe important issues regarding practice characteristics, product preferences, surgical techniques, and practice marketing and captures market share by manufacturer, product and market segment, and perceptions of companies.

The 2024 survey was conducted during March and April 2024 and received 110 responses from doctors performing cataract procedures, representing over 1 thousand total doctors in single doctor and group practices.  

This survey highlights practice patterns regarding presbyopia-correcting IOLs (PC-IOLs), toric IOLs, extended depth of focus (EDOF) IOLs, correction of astigmatism, femtosecond laser-assisted cataract surgery (FLACS), surgical location, interest in upcoming technology, equipment use, treatment and management of glaucoma and micro-invasive glaucoma surgery (MIGS) devices, and much more. It measures market share by manufacturer, product, and market segment.

Leading ophthalmic firms and organizations sponsor the survey to better understand industry dynamics and gain important insights into surgeons’ experiences and preferences, as well as emerging trends. 

The “2024 United States Cataract Atlas” provides a geographic analysis of the conventional and premium cataract surgery opportunity in 85 US metropolitan areas. Market Scope’s proprietary MedOp Index™ Analysis examines market potential and provides a benchmark against other metros. The atlas offers strategic insights into the top potential markets in the US, which companies often use throughout the development and commercialization processes to identify ideal clinical trial locations, develop launch strategies, define sales territories, allocate resources, and optimize sales and marketing initiatives.

The “2024 United States Refractive Atlas” provides a geographic analysis of the US refractive market in 85 metropolitan areas. Market Scope’s MedOp Index™ Analysis is used to identify the potential for refractive surgery and considers many factors for each geography, including:  population age distribution, refractive error, income/buying power, overall health, education level, and location of refractive surgeons and LVC centers. High-opportunity populations and benchmarking comparisons are provided for each metropolitan area. Additionally, the atlas provides a comprehensive directory of all US practices offering refractive surgery. Market Scope also offers customization of atlas data to align with sales territories or specific geographic areas.

The “2024 Retinal Surgical Device Market Report” provides in-depth analysis of the global retinal device market, examining the market’s size and growth, as well as identifying important developments that may shape its future. The analysis focuses on the 2024 market and forecasts market growth and evolution through 2029. Additionally, 21 retina device companies are profiled, with discussion of their products, strategic market position, background, and outlook.

Market Scope’s "2023 Dry Eye Disease Model" offers extensive country-level prevalence data and five-year forecasts for 13 dry eye-related segments of the population by age group for all countries with a population over a million.

This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients’ diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.

The “2023 Refractive Surgery Market Report” analyzes the global refractive and presbyopia-correcting market, identifying important trends and key factors for future success. It focuses on the 2023 refractive and presbyopia-correcting surgical market and forecasts market growth and evolution over the next five years. Included are discussions and market estimates for LASIK, lenticular extraction, phakic IOLs, corneal inlays, refractive lens exchange (RLE), and other technologies that may disrupt the market.